Key result
Modern management of pulmonary embolism relies on echocardiography and CT angiography for rapid diagnosis, and increasingly utilizes novel oral anticoagulants for effective treatment and prevention.
This review provides a comprehensive overview of modern diagnostic algorithms and therapeutic strategies, including the use of new oral anticoagulants, for the management of pulmonary embolism.
Consolidates contemporary PE diagnostic and NOAC strategies for clinicians; extends prior syntheses while leaving optimal subgroup application open.
Pulmonary embolism (PE) is one of the most common diseases, comparable in frequency with acute coronary syndrome, and is one of the leading causes of cardiovascular mortality. The high mortality associated with pulmonary embolism (PE) is determined by the severity of the disease and the difficulties of diagnosis and in large part by a lack of awareness of doctors on standards for primary prevention.The last decade has been marked by qualitative improvement in the efficiency of diagnosis of pulmonary embolism, which resulted from the achievements in echocardiography and increased availability of computer tomography imaging in real practice. The list of availbale anticoagulant drugs which are the basis of pathogenetic treatment, secondary and primary prevention of pulmonary embolism expanded significantly. The present review covers the principles of diagnosis, therapy and prevention of this disease.
No takes yet. Share an insight, caveat, or question.
L. L. Bershteyn (2014) conducted a review in Pulmonary embolism. Diagnostic, therapeutic, and preventive strategies was evaluated. Modern management of pulmonary embolism relies on echocardiography and CT angiography for rapid diagnosis, and increasingly utilizes novel oral anticoagulants for effective treatment and prevention.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: